Evidence map›Paper›PMID 23234363›Full record

ArticleBMC immunology2012

Identification and characterization of H-2d restricted CD4+ T cell epitopes on Lpp20 of Helicobacter pylori.

Yan Li, Yin Jiang, Yue Xi, Lili Zhang, Jun Luo, Diandian He, Shuang Zeng, Yunshan Ning

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Notch 1 Is Involved in CD4Frontiers in cellular and infection microbiology · 2020
    Article
  2. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2019
    Review
  3. Identification of Two Lpp20 CD4Frontiers in microbiology · 2018
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yan LiInstitute of Biotherapy, School of Biotechnology, Southern Medical University, North1838 Guangzhou Road, Guangzhou 510515, PR China. liyan_nys@hotmail.com
Yin Jiang
Yue Xi
Lili Zhang
Jun Luo
Diandian He
Shuang Zeng
Yunshan Ning
Southern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious investigation has demonstrated that CD4+ T cells play a crucial role in effective immunity against Helicobacter pylori (H.pylori) infection. It has been well proved that Lpp20 is one of major protective antigens that induce immune responses after H.pylori invades host. Therefore it is valuable to identify CD4+ T cell epitopes on Lpp20, which is uncharacterized.

methodsPutative epitopes of H-2d restricted CD4+ T cell on Lpp20 of H.pylori were predicted by the SYFPEITHI algorithm and then eight hypothetical epitope peptides were synthesized. After BALB/c mice were primed with recombinant Lpp20, splenic CD4+ T cells were isolated and stimulated with synthesized peptides to measure T cell proliferation and MHC restriction. Cytokine profile was determined by ELISA and real-time PCR. Two identified epitopes were used to immunize mice to investigate CD4+ T cell response by flow cytometry.

resultsTwo of eight peptides were able to stimulate CD4+ T cell proliferation and were mapped to residues 83-97aa and 58-72aa on Lpp20 respectively. These two peptides additively stimulated Th1 cells to secrete IFN-γ. The percentage of CD4+ T cell from mice immunized with two identified epitopes respectively was higher than the control group.

conclusionThe identification and characterization of two CD4+ T cell epitopes of Lpp20 helps understand the protective immunity of Lpp20 in H.pylori infection and design effective epitope vaccines against H.pylori.

Indexed as

Amino Acid SequenceAnimalsAntigens, BacterialCD4-Positive T-LymphocytesCell ProliferationCytokinesEpitopes, T-LymphocyteFemaleHelicobacter pyloriHistocompatibility Antigens Class IHistocompatibility Antigens Class IIImmunizationLipoproteinsMiceMice, Inbred BALB CMolecular Sequence DataAntigens, BacterialCytokinesEpitopes, T-LymphocyteHistocompatibility Antigens Class IHistocompatibility Antigens Class IILipoproteinsLpp20 protein, Helicobacter pyloriPeptides

Identifiers

PMID23234363
PMCPMC3534527
OpenAlexW1992227740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.